Measurement of liver T 1 and T 2 relaxation times in an experimental mouse model of liver fibrosis

Journal of Magnetic Resonance Imaging

Volumn 36, Issue 1, 2012, Pages 152-158

  Chow, April M ^a   Gao, Darwin S ^a   Fan, Shu Juan ^a   Qiao, Zhongwei ^a   Lee, Frank Y ^a   Yang, Jian ^a   Man, Kwan ^a   Wu, Ed X ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

CCl 4; liver fibrosis; MRI; T 1, T 2 relaxometry

Indexed keywords

CARBON TETRACHLORIDE; COLLAGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE MODEL; EDEMA; HISTOPATHOLOGY; IMAGE ANALYSIS; INFLAMMATORY CELL; LIVER FIBROSIS; LIVER PARENCHYMA; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAXATION TIME; SPINAL CORD;

ALGORITHMS; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84862747595     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23606     Document Type: Article

References (80)

1. Friedman SL,. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828-1835. (Pubitemid 23174715)
2. Bataller R, Brenner DA,. Liver fibrosis. J Clin Invest 2005; 115: 209-218. (Pubitemid 40385459)
3. Arthur MJ,. Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology 2002; 122: 1525-1528. (Pubitemid 34465193)
4. Manning DS, Afdhal NH,. Diagnosis and quantitation of fibrosis. Gastroenterology 2008; 134: 1670-1681. (Pubitemid 351615414)
5. Afdhal NH, Nunes D,. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004; 99: 1160-1174. (Pubitemid 38917824)
6. Fontana RJ, Lok AS,. Noninvasive monitoring of patients with chronic hepatitis C. Hepatology 2002; 36: S57-64. (Pubitemid 35253464)
7. Zhou K, Lu LG,. Assessment of fibrosis in chronic liver diseases. J Dig Dis 2009; 10: 7-14.
8. Ito K, Mitchell DG,. Hepatic morphologic changes in cirrhosis: MR imaging findings. Abdom Imaging 2000; 25: 456-461. (Pubitemid 30659297)
9. Awaya H, Mitchell DG, Kamishima T, Holland G, Ito K, Matsumoto T,. Cirrhosis: modified caudate-right lobe ratio. Radiology 2002; 224: 769-774. (Pubitemid 34919811)
10. Martin DR,. Magnetic resonance imaging of diffuse liver diseases. Top Magn Reson Imaging 2002; 13: 151-163.
11. Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB,. Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology 2006; 239: 425-437.
12. Hughes-Cassidy F, Chavez AD, Schlang A, et al. Superparamagnetic iron oxides and low molecular weight gadolinium chelates are synergistic for direct visualization of advanced liver fibrosis. J Magn Reson Imaging 2007; 26: 728-737. (Pubitemid 350194599)
13. Huwart L, Peeters F, Sinkus R, et al. Liver fibrosis: non-invasive assessment with MR elastography. NMR Biomed 2006; 19: 173-179.
14. Rouviere O, Yin M, Dresner MA, et al. MR elastography of the liver: preliminary results. Radiology 2006; 240: 440-448. (Pubitemid 44098640)
15. Kucharczyk J, Mintorovitch J, Asgari HS, Moseley M,. Diffusion/perfusion MR imaging of acute cerebral ischemia. Magn Reson Med 1991; 19: 311-315.
16. Basser PJ, Mattiello J, LeBihan D,. MR diffusion tensor spectroscopy and imaging. Biophys J 1994; 66: 259-267. (Pubitemid 24016507)
17. Mori S, van Zijl PC,. Diffusion weighting by the trace of the diffusion tensor within a single scan. Magn Reson Med 1995; 33: 41-52.
18. Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H,. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echo-planar MR imaging. Radiology 1999; 210: 617-623. (Pubitemid 29124018)
19. Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, Menu Y,. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 2003; 226: 71-78. (Pubitemid 36163910)
20. Moteki T, Horikoshi H,. Evaluation of hepatic lesions and hepatic parenchyma using diffusion-weighted echo-planar MR with three values of gradient b-factor. J Magn Reson Imaging 2006; 24: 637-645. (Pubitemid 44320568)
21. Bruegel M, Holzapfel K, Gaa J, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 2008; 18: 477-485. (Pubitemid 351248179)
22. Goshima S, Kanematsu M, Kondo H, et al. Diffusion-weighted imaging of the liver: optimizing b value for the detection and characterization of benign and malignant hepatic lesions. J Magn Reson Imaging 2008; 28: 691-697.
23. Boulanger Y, Amara M, Lepanto L, et al. Diffusion-weighted MR imaging of the liver of hepatitis C patients. NMR Biomed 2003; 16: 132-136. (Pubitemid 36950058)
24. Koinuma M, Ohashi I, Hanafusa K, Shibuya H,. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging 2005; 22: 80-85. (Pubitemid 40885132)
25. Annet L, Peeters F, Abarca-Quinones J, Leclercq I, Moulin P, Van Beers BE,. Assessment of diffusion-weighted MR imaging in liver fibrosis. J Magn Reson Imaging 2007; 25: 122-128. (Pubitemid 46098861)
26. Girometti R, Furlan A, Bazzocchi M, et al. Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients. Radiol Med 2007; 112: 394-408. (Pubitemid 46663985)
27. Lewin M, Poujol-Robert A, Boelle PY, et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 2007; 46: 658-665. (Pubitemid 47436110)
28. Taouli B, Tolia AJ, Losada M, et al. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol 2007; 189: 799-806. (Pubitemid 47479760)
29. Girometti R, Furlan A, Esposito G, et al. Relevance of b-values in evaluating liver fibrosis: a study in healthy and cirrhotic subjects using two single-shot spin-echo echo-planar diffusion-weighted sequences. J Magn Reson Imaging 2008; 28: 411-419.
30. Luciani A, Vignaud A, Cavet M, et al. Liver cirrhosis: intravoxel incoherent motion MR imaging-pilot study. Radiology 2008; 249: 891-899.
31. Taouli B, Chouli M, Martin AJ, Qayyum A, Coakley FV, Vilgrain V,. Chronic hepatitis: role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging 2008; 28: 89-95. (Pubitemid 351956470)
32. Sandrasegaran K, Akisik FM, Lin C, et al. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol 2009; 193: 1556-1560.
33. Chamuleau RA, Creyghton JH, De Nie I, Moerland MA, Van der Lende OR, Smidt J,. Is the magnetic resonance imaging proton spin-lattice relaxation time a reliable noninvasive parameter of developing liver fibrosis? Hepatology 1988; 8: 217-221.
34. Aube C, Moal F, Oberti F, et al. Diagnosis and measurement of liver fibrosis by MRI in bile duct ligated rats. Dig Dis Sci 2007; 52: 2601-2609. (Pubitemid 47373868)
35. Aisen AM, Doi K, Swanson SD,. Detection of liver fibrosis with magnetic cross-relaxation. Magn Reson Med 1994; 31: 551-556. (Pubitemid 24129951)
36. Lee MJ, Kim MJ, Yoon CS, Han SJ, Park YN,. Evaluation of liver fibrosis with T2 relaxation time in infants with cholestasis: comparison with normal controls. Pediatr Radiol 2011; 41: 350-354.
37. Guimaraes AR, Siqueira L, Boland G, et al. T2 relaxation time as a surrogate marker of liver fibrosis. In: Proceedings of the 19th Annual Meeting of the ISMRM, Montreal, Quebec, Canada, 2011. p. 395.
38. Siqueira L, Chew M, Hahn PF, et al. T2 relaxation time as a surrogate marker of liver fibrosis. In: Proceedings of the 18th Annual Meeting of the ISMRM, Stockholm, Sweden, 2010. p. 259.
39. Colombo M,. The role of hepatitis C virus in hepatocellular carcinoma. Recent Results Cancer Res 1998; 154: 337-344.
40. Brechot C,. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms. Gastroenterology 2004; 127: S56-61. (Pubitemid 39423370)
41. Cuadrado A, Orive A, Garcia-Suarez C, et al. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma. Obes Surg 2005; 15: 442-446. (Pubitemid 40463617)
42. Voigt MD,. Alcohol in hepatocellular cancer. Clin Liver Dis 2005; 9: 151-169. (Pubitemid 40341951)
43. de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC,. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 2004; 230: 652-659. (Pubitemid 38252858)
44. Hosch W, Bock M, Libicher M, et al. MR-relaxometry of myocardial tissue: significant elevation of T1 and T2 relaxation times in cardiac amyloidosis. Invest Radiol 2007; 42: 636-642. (Pubitemid 47262932)
45. Sijens PE,. Parametric exploration of the liver by magnetic resonance methods. Eur Radiol 2009; 19: 2594-2607.
46. Kim D, Jensen JH, Wu EX, Sheth SS, Brittenham GM,. Breathhold multiecho fast spin-echo pulse sequence for accurate R2 measurement in the heart and liver. Magn Reson Med 2009; 62: 300-306.
47. Guo H, Au WY, Cheung JS, et al. Myocardial T2 quantitation in patients with iron overload at 3 Tesla. J Magn Reson Imaging 2009; 30: 394-400.
48. Constandinou C, Henderson N, Iredale JP,. Modeling liver fibrosis in rodents. Methods Mol Med 2005; 117: 237-250.
49. Proctor E, Chatamra K,. Controlled induction of cirrhosis in the rat. Br J Exp Pathol 1983; 64: 320-330. (Pubitemid 13037192)
50. Cheung JS, Fan SJ, Gao DS, et al. In vivo lipid profiling using proton magnetic resonance spectroscopy in an experimental liver fibrosis model. Acad Radiol 2011; 18: 377-383.
51. Kim H, Booth CJ, Pinus AB, et al. Induced hepatic fibrosis in rats: hepatic steatosis, macromolecule content, perfusion parameters, and their correlations-preliminary MR imaging in rats. Radiology 2008; 247: 696-705.
52. Tretheway D, Jain A, LaPoint R, et al. Should trichrome stain be used on all post-liver transplant biopsies with hepatitis C virus infection to estimate the fibrosis score? Liver Transpl 2008; 14: 695-700. (Pubitemid 351696284)
53. Zhao XY, Wang BE, Li XM, Wang TL,. Newly proposed fibrosis staging criterion for assessing carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents. Pathol Int 2008; 58: 580-588.
54. Hazle JD, Narayana PA, Dunsford HA,. Chronic carbon tetrachloride and phospholipase D hepatotoxicity in rat: in vivo 1H magnetic resonance, total lipid analysis, and histology. Magn Reson Med 1990; 15: 211-228. (Pubitemid 20278259)
55. Goldberg MA, Hahn PF, Saini S, et al. Value of T1 and T2 relaxation times from echoplanar MR imaging in the characterization of focal hepatic lesions. AJR Am J Roentgenol 1993; 160: 1011-1017. (Pubitemid 23141240)
56. Cheung JS, Au WY, Ha SY, et al. Reduced transverse relaxation rate (RR2) for improved sensitivity in monitoring myocardial iron in thalassemia. J Magn Reson Imaging 2011; 33: 1510-1516.
57. Inch WR, McCredie JA, Knispel RR, Thompson RT, Pintar MM,. Water content and proton spin relaxation time for neoplastic and non-neoplastic tissues from mice and humans. J Natl Cancer Inst 1974; 52: 353-356.
58. Kiricuta IC Jr, Simplaceanu V,. Tissue water content and nuclear magnetic resonance in normal and tumor tissues. Cancer Res 1975; 35: 1164-1167.
59. Hollis DP, Saryan LA, Eggleston JC, Morris HP,. Nuclear magnetic resonance studies of cancer. VI. Relationship among spin-lattice relaxation times, growth rate, and water content of Morris hepatomas. J Natl Cancer Inst 1975; 54: 1469-1472.
60. Mathur-De Vre R,. Biomedical implications of the relaxation behaviour of water related to NMR imaging. Br J Radiol 1984; 57: 955-976. (Pubitemid 15213087)
61. Friedman SL,. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-2250. (Pubitemid 30081976)
62. Wynn TA,. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214: 199-210. (Pubitemid 351160157)
63. Thomsen C,. Quantitative magnetic resonance methods for in vivo investigation of the human liver and spleen. Technical aspects and preliminary clinical results. Acta Radiol Suppl 1996; 401: 1-34.
64. Pardoe H, Chua-anusorn W, St Pierre TG, Dobson J,. Detection limits for ferrimagnetic particle concentrations using magnetic resonance imaging based proton transverse relaxation rate measurements. Phys Med Biol 2003; 48: N89-95. (Pubitemid 36410410)
65. Jacob RE, Amidan BG, Soelberg J, Minard KR,. In vivo MRI of altered proton signal intensity and T2 relaxation in a bleomycin model of pulmonary inflammation and fibrosis. J Magn Reson Imaging 2010; 31: 1091-1099.
66. Siqueira L, Chew M, Hahn PF, et al. T2 relaxation time as a surrogate marker of liver fibrosis. In: Proc 18th Annual Meeting ISMRM, Stockholm; 2010: 259.
67. Tsukamoto H, Matsuoka M, French SW,. Experimental models of hepatic fibrosis: a review. Semin Liver Dis 1990; 10: 56-65. (Pubitemid 20163706)
68. Wu J, Norton PA,. Animal models of liver fibrosis. Scand J Gastroenterol 1996; 31: 1137-1143. (Pubitemid 26403086)
69. de Graaf RA, Brown PB, McIntyre S, Nixon TW, Behar KL, Rothman DL,. High magnetic field water and metabolite proton T1 and T2 relaxation in rat brain in vivo. Magn Reson Med 2006; 56: 386-394. (Pubitemid 44162787)
70. Oros-Peusquens AM, Laurila M, Shah NJ,. Magnetic field dependence of the distribution of NMR relaxation times in the living human brain. Magma 2008; 21: 131-147.
71. Franconi F, Lemaire L, Marescaux L, Jallet P, Le Jeune JJ,. In vivo quantitative microimaging of rat spinal cord at 7T. Magn Reson Med 2000; 44: 893-898.
72. Stanisz GJ, Odrobina EE, Pun J, et al. T1, T2 relaxation and magnetization transfer in tissue at 3T. Magn Reson Med 2005; 54: 507-512.
73. Goldstein NS, Hastah F, Galan MV, Gordon SC,. Fibrosis heterogeneity in nonalcoholic steatohepatitis and hepatitis C virus needle core biopsy specimens. Am J Clin Pathol 2005; 123: 382-387. (Pubitemid 40315079)
74. Su MY, Nalcioglu O,. Statistical description of microcirculatory flow as measured with an MR method. J Magn Reson Imaging 1993; 3: 883-887.
75. Boxerman JL, Hamberg LM, Rosen BR, Weisskoff RM,. MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med 1995; 34: 555-566.
76. Stark DD, Moseley ME, Bacon BR, et al. Magnetic resonance imaging and spectroscopy of hepatic iron overload. Radiology 1985; 154: 137-142. (Pubitemid 15196301)
77. Chai JW, Lin YC, Chen JH, et al. In vivo magnetic resonance (MR) study of fatty liver: importance of intracellular ultrastructural alteration for MR tissue parameters change. J Magn Reson Imaging 2001; 14: 35-41.
78. Cheung JS, Fan SJ, Gao DS, Chow AM, Man K, Wu EX,. Diffusion tensor imaging of liver fibrosis in an experimental model. J Magn Reson Imaging 2010; 32: 1141-1148.
79. Cho SG, Kim MY, Kim HJ, et al. Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology 2001; 221: 740-746.
80. Orlacchio A, Bolacchi F, Angelico M, et al. In vivo, high-field, 3-Tesla 1H MR spectroscopic assessment of liver fibrosis in HCV-correlated chronic liver disease. Radiol Med 2008; 113: 289-299. (Pubitemid 351666947)